Rein Willemze

Active 1982–2025

148
Papers
31,772
Citations
95
h-index
144
i10-index

Citations

Citations per year for Rein Willemze1983: 1 citations1984: 2 citations1985: 4 citations1986: 5 citations1987: 6 citations1988: 2 citations1989: 9 citations1990: 10 citations1991: 9 citations1992: 10 citations1993: 14 citations1994: 34 citations1995: 29 citations1996: 36 citations1997: 59 citations1998: 32 citations1999: 72 citations2000: 92 citations2001: 83 citations2002: 96 citations2003: 131 citations2004: 96 citations2005: 179 citations2006: 173 citations2007: 162 citations2008: 198 citations2009: 207 citations2010: 174 citations2011: 174 citations2012: 171 citations2013: 178 citations2014: 167 citations2015: 159 citations2016: 123 citations2017: 115 citations2018: 121 citations2019: 550 citations2020: 536 citations2021: 559 citations2022: 398 citations2023: 229 citations2024: 404 citations2025: 155 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,313 citing papers, 24.8% of this breakdownGermany: 391 citing papers, 7.4% of this breakdownUnited Kingdom: 372 citing papers, 7% of this breakdownItaly: 343 citing papers, 6.5% of this breakdownFrance: 320 citing papers, 6% of this breakdownNetherlands: 299 citing papers, 5.7% of this breakdownSpain: 188 citing papers, 3.6% of this breakdownSwitzerland: 179 citing papers, 3.4% of this breakdownJapan: 174 citing papers, 3.3% of this breakdownChina: 173 citing papers, 3.3% of this breakdownAustria: 160 citing papers, 3% of this breakdownCanada: 146 citing papers, 2.8% of this breakdown
0%24.8%Other 23.2%

Fields

  • Medicine79.3%
  • Biochemistry, Genetics and Molecular Biology10.1%
  • Immunology and Microbiology7.8%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Environmental Science0.4%
  • Engineering0.3%
  • Other1.6%

Topics

  • Cutaneous lymphoproliferative disorders research15.3%
  • Lymphoma Diagnosis and Treatment12.9%
  • T-cell and Retrovirus Studies3.8%
  • Fungal Infections and Studies3.2%
  • CNS Lymphoma Diagnosis and Treatment2.8%
  • Nail Diseases and Treatments2.3%
  • Other59.7%

Coauthors

All papers

Open in search
  1. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas

    Authors: , , , , , , - Blood 2019 cited by 1,382

  2. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2023 cited by 164

  3. WHO-EORTC classification for cutaneous lymphomas

    Authors: - Blood 2005 cited by 3,801

  4. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

    Authors: , , , , , , , , , , , , , , , , , , , , - Blood 2007 cited by 1,416

  5. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jasmine M. Zain, Robert Knobler, Rudolf Stadler, M. Bagot, Julia Scarisbrick - Blood 2021 cited by 171

  6. Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter Heald, Steven T. Rosen, Lorenzo Cerroni, Brigette Dréno, Eric C. Vonderheid - Journal of Clinical Oncology 2011 cited by 658

  7. Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cristina Muniesa, Emilio Berti, Francesco Onida, Laura Corti, Emilia Hodak, Iris Amitay‐Laish, Pablo L. Ortiz‐Romero, José Luis Rodríguez‐­Peralto, Robert Knobler, Stefanie Porkert, Wolfgang Bauer, Nicola Pimpinelli, Vieri Grandi, Richard Cowan, Alain H. Rook, Ellen Kim, Alessandro Pileri, Annalisa Patrizi, Ramón M. Pujol, Henry K. Wong, Kelly Tyler, René Stranzenbach, Christiane Querfeld, Paolo Fava, Milena Maule, Rein Willemze, Felicity Evison, Stephen Morris, Robert Twigger, Rakhshandra Talpur, Jinah Kim, G. Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, Madeleine Duvic, Sean Whittaker, Youn H. Kim - Journal of Clinical Oncology 2015 cited by 421

  8. WHO classification of skin tumours

    Authors: , , , - IARC eBooks 2018 cited by 422

  9. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017

    Authors: , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2017 cited by 449

  10. Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrea Combalía, Stephanie K. Fabbro, Paolo Fava, Vieri Grandi, Constanze Jonak, Estela Martínez-Escala, Meenal Kheterpal, E.J. Kim, Christopher McCormack, Tomomitsu Miyagaki, Denis Miyashiro, Stephen Morris, Cristina Muniesa, Vasiliki Nikolaou, G. Ognibene, Francesco Onida, Simona Osella‐Abate, Stefanie Porkert, Concepción Postigo‐Llorente, C. Ram‐Wolff, Simone Ribero, Kortney Rogers, Martina Sanlorenzo, René Stranzenbach, Natalie Spaccarelli, Andrew Stevens, Daniela Zugna, Alain H. Rook, Larisa J. Geskin, Rein Willemze, Sean Whittaker, Richard T. Hoppe, Julia Scarisbrick, Y. Kim - Annals of Oncology 2017 cited by 136

  11. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’1

    Authors: , , , , , , , , , , , , , , , , , , , , - British Journal of Haematology 2004 cited by 610

  12. TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)

    Authors: , , , , , , , - Blood 2007 cited by 490

  13. An Immunodeficiency Disease withRAGMutations and Granulomas

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2008 cited by 218

  14. Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases

    Authors: , , , - Blood 2011 cited by 213

  15. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2007 cited by 697

  16. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , - Annals of Oncology 2013 cited by 294

  17. The CXCR3 Targeting Chemokine CXCL11 Has Potent Antitumor Activity In Vivo Involving Attraction of CD8+ T Lymphocytes But Not Inhibition of Angiogenesis

    Authors: , , , , , - Journal of Immunotherapy 2005 cited by 131

  18. Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study*

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paula Enz, Marion Wobser, Mike Bayne, Constanze Jonak, M. Rubeta, Angus Forbes, Andrew Bates, Maxime Battistella, Rasoul Amel-Kashipaz, B. Vydianath, Andrea Combalía, Elisavet Georgiou, Esther Hauben, Eric Hong, Marion Jost, Robert Knobler, Iris Amitay‐Laish, Denis Miyashiro, Jade Cury‐Martins, X. Martínez, Cristina Muniesa, Hadas Prag-Naveh, Alexander Stratigos, Vasiliki Nikolaou, Koen D. Quint, C. Ram‐Wolff, Kerri E. Rieger, René Stranzenbach, Ágota Szepesi, S. Alberti‐Violetti, E. Felicity, Lorenzo Cerroni, Werner Kempf, Sean Whittaker, Rein Willemze, Y Kim, Julia Scarisbrick - British Journal of Dermatology 2020 cited by 85

  19. The Influence of Painful Sunburns and Lifetime Sun Exposure on the Risk of Actinic Keratoses, Seborrheic Warts, Melanocytic Nevi, Atypical Nevi, and Skin Cancer

    Authors: , , , , - Journal of Investigative Dermatology 2003 cited by 364

  20. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation

    Authors: , , , , , , - The Journal of Pathology 2001 cited by 356

  21. Reclassification of 300 Primary Cutaneous B-Cell Lymphomas According to the New WHO–EORTC Classification for Cutaneous Lymphomas: Comparison With Previous Classifications and Identification of Prognostic Markers

    Authors: , , , , , , , , , , , , - Journal of Clinical Oncology 2007 cited by 311

  22. Low-Dose Palliative Radiotherapy for Cutaneous B- and T-Cell Lymphomas

    Authors: , , , , , - International Journal of Radiation Oncology*Biology*Physics 2008 cited by 173

  23. Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients

    Authors: , , , , , , , , - BMC Cancer 2013 cited by 118

  24. Deregulation of JAK2 signaling underlies primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma

    Authors: , , , , , , , , , - Haematologica 2021 cited by 48